Your browser doesn't support javascript.
loading
The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy.
Buckley, S A; Othus, M; Estey, E H; Walter, R B.
Afiliación
  • Buckley SA; Hematology/Oncology Fellowship Program, University of Washington, Seattle, WA, USA.
  • Othus M; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Estey EH; 1] Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA [2] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Walter RB; 1] Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA [2] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [3] Department of Epidemiology, University of Washington, Seattle, WA, USA.
Blood Cancer J ; 5: e276, 2015 Jan 30.
Article en En | MEDLINE | ID: mdl-25635529

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Neoplasias Primarias Secundarias / Quimioterapia / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Neoplasias Primarias Secundarias / Quimioterapia / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos